Lynnet S Koh
age ~62
from Carlsbad, CA
- Also known as:
-
- Lynnet Sl Koh
- Sui L Koh
- Lynette Koh
- Lynnet Lemaire
- Lynne Sl Koh
- Phone and address:
-
135 Chinquapin Ave, Carlsbad, CA 92008
760 434-8644
Lynnet Koh Phones & Addresses
- 135 Chinquapin Ave, Carlsbad, CA 92008 • 760 434-8644 • 760 434-8646
- Floresville, TX
- 11014 Bar X Trl, Helotes, TX 78023 • 210 637-9227 • 210 695-8307
- San Diego, CA
- 174 Ely St, Oceanside, CA 92054
- Morristown, NJ
- Alexandria, VA
- 135 Chinquapin Ave, Carlsbad, CA 92008 • 760 434-8646
Work
-
Position:Professional/Technical
Education
-
Degree:Associate degree or higher
Emails
Name / Title
Company / Classification
Phones & Addresses
Principal
America Stem Cell Bank Inc
Business Services at Non-Commercial Site
Business Services at Non-Commercial Site
135 Chinquapin Ave, Carlsbad, CA 92008
Director , Chief Executive Offi
AMERICA STEM CELL, INC
11014 Bar X Trl, Helotes, TX 78023
Resumes
Executive Chairman And Founder
view sourceLocation:
135 Chinquapin Ave, Carlsbad, CA 92008
Industry:
Biotechnology
Work:
Targazyme
Executive Chairman and Founder
Cisco 1999 - 2003
Program Leader - Voice Over Internet New Business Venture
Qualcomm 1997 - 1999
Head of Product Management
At&T 1986 - 1997
Strategic Business Unit Management, General Manager of New Business Ventures
M&M Mars Procter & Gamble 1984 - 1986
Brand Management Internship
Executive Chairman and Founder
Cisco 1999 - 2003
Program Leader - Voice Over Internet New Business Venture
Qualcomm 1997 - 1999
Head of Product Management
At&T 1986 - 1997
Strategic Business Unit Management, General Manager of New Business Ventures
M&M Mars Procter & Gamble 1984 - 1986
Brand Management Internship
Education:
Massachusetts Institute of Technology 1986 - 1988
Master of Business Administration, Masters Boston University 1982 - 1984
Bachelor of Applied Science, Bachelors, Marketing, Finance Marymount Convent Secondary School
Master of Business Administration, Masters Boston University 1982 - 1984
Bachelor of Applied Science, Bachelors, Marketing, Finance Marymount Convent Secondary School
Skills:
Medical Devices
Start Ups
Biotechnology
Lifesciences
Product Development
Strategy
Patents
Commercialization
Clinical Development
Clinical Trials
New Business Development
Technology Transfer
Venture Capital
Cancer
Mergers and Acquisitions
Biopharmaceuticals
Licensing
Fda
Drug Development
Pharmaceutical Industry
Drug Discovery
Corporate Development
Product Management
R&D
Strategic Alliances
Oncology
Cro
Regulatory Affairs
Clinical Research
Market Development
Life Sciences
Business Development
Start Ups
Biotechnology
Lifesciences
Product Development
Strategy
Patents
Commercialization
Clinical Development
Clinical Trials
New Business Development
Technology Transfer
Venture Capital
Cancer
Mergers and Acquisitions
Biopharmaceuticals
Licensing
Fda
Drug Development
Pharmaceutical Industry
Drug Discovery
Corporate Development
Product Management
R&D
Strategic Alliances
Oncology
Cro
Regulatory Affairs
Clinical Research
Market Development
Life Sciences
Business Development
Interests:
Car Racing
Sweepstakes
Home Improvement
Art
Psychology History
Geology
Sports
See 5
Home Decoration
Blues
Electronics
Outdoors
Architecture Design Creating
Dancing
Music
Invention
Classical
Somewhat of A Francophile
Physical Training
Rock
Ballet
Travel
Boating
Investing
Anthropology
Archaeology
See Less
Jazz
Sports Cars
Adventure and Exploration
Sweepstakes
Home Improvement
Art
Psychology History
Geology
Sports
See 5
Home Decoration
Blues
Electronics
Outdoors
Architecture Design Creating
Dancing
Music
Invention
Classical
Somewhat of A Francophile
Physical Training
Rock
Ballet
Travel
Boating
Investing
Anthropology
Archaeology
See Less
Jazz
Sports Cars
Adventure and Exploration
Languages:
English
Owner
view sourceLocation:
Carlsbad, CA
Industry:
Biotechnology
Work:
America Stem Cell
Owner
Owner
Education:
Mit Sloan School of Management 1982 - 1986
Us Patents
-
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1-3 Fucosyltransferase
view source -
US Patent:20110091434, Apr 21, 2011
-
Filed:Jun 9, 2009
-
Appl. No.:12/997230
-
Inventors:Len Miller - Carlsbad CA, US
Lynnet Koh - Carlsbad CA, US
Thomas E. Ichim - San Diego CA, US -
Assignee:AMERICA STEM CELL, INC. - Carlsbad CA
-
International Classification:A61K 35/14
A61K 35/12
C12N 5/071
C12N 5/0783
C12N 5/0787
C12N 5/0786
C12N 5/074
C12N 5/0797
C12N 5/0735
A61K 35/30
A61K 35/34
A61K 35/50
A61K 35/28
A61K 35/36
A61P 35/00
A61P 37/02
A61P 9/00
A61P 9/10
A61P 3/10
A61P 1/16
A61P 19/08
A61P 25/28
A61P 21/00
A61P 25/16
A61P 25/00
A61P 15/00 -
US Classification:424 9371, 424 937, 435375
-
Abstract:Disclosed are methods, compositions of matter, and kits useful for augmentation of homing and engraftment of stem, progenitor and mature cells through modification of cellular membrane properties following ex vivo treatment. The methods, compositions, and cells may be used for the treatment of a wide variety of disorders in which augmentation of cell trafficking, homing and engraftment is desired.
-
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase
view source -
US Patent:20190017023, Jan 17, 2019
-
Filed:Sep 19, 2018
-
Appl. No.:16/135487
-
Inventors:- Carlsbad CA, US
Leonard Miller - Carlsbad CA, US
Lynnet Koh - Carlsbad CA, US
Thomas E. Ichim - San Diego CA, US -
International Classification:C12N 5/0783
C12N 5/00
C12N 5/0775
C12N 5/0789
A61K 35/17
C12N 5/0797
A61K 35/12 -
Abstract:Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
-
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase
view source -
US Patent:20170058261, Mar 2, 2017
-
Filed:Nov 9, 2016
-
Appl. No.:15/347500
-
Inventors:- Carlsbad CA, US
Leonard Miller - Carlsbad CA, US
Lynnet Koh - Carlsbad CA, US -
International Classification:C12N 5/0783
A61K 35/17
C12N 5/00 -
Abstract:Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
-
Augmentation Of Cell Therapy Efficacy Including Treatment With Alpha 1-3 Fucoslytransferase
view source -
US Patent:20140161782, Jun 12, 2014
-
Filed:Feb 17, 2014
-
Appl. No.:14/182141
-
Inventors:- Carlsbad CA, US
Leonard Miller - Carlsbad CA, US
Lynnet Koh - Carlsbad CA, US -
Assignee:Targazyme, Inc. - Carlsbad CA
-
International Classification:C12N 5/0783
A61K 35/14 -
US Classification:424 9371, 435375
-
Abstract:Disclosed are methods, compositions of matter, and kits useful for augmentation of cells through modification of cellular membrane properties following ex vivo treatment.
Lynnet Koh
view sourceYoutube
News
Texas governor's startup fund is not all it seems
view source- Targazyme founder Lynnet Koh said her company is moving forward but that she left Texas because Perry's office withheld additional funding, a complaint echoed by other recipients. She now lives in California and said many of the jobs created by the company were short-term hires outside Texas, none o
- Date: Jul 24, 2014
- Category: U.S.
- Source: Google
Get Report for Lynnet S Koh from Carlsbad, CA, age ~62